Humankind Pharmaceutical And Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
About Humankind Pharmaceutical And Lifesciences
Humankind Pharmaceutical And Lifesciences Private Limited (HPALPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 September 2020 (Four years and five months 6 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Bohra and Bela Bohra serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299MH2020PTC345248
-
Company No.
345248
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Sep 2020
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Humankind Pharmaceutical And Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Bohra
|
Director | 03-Sep-2020 | Current |
|
Bela Bohra
|
Director | 03-Sep-2020 | Current |
Financial Performance of Humankind Pharmaceutical And Lifesciences.
Enhance accessibility to Humankind Pharmaceutical And Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Humankind Pharmaceutical And Lifesciences?
Unlock access to Humankind Pharmaceutical And Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Bjw Health Private LimitedPrashant Bohra is a mutual person
-
Bright Genesis Private Limited
Prashant Bohra is a mutual person
-
Abpv Ventures Private Limited
Bela Bohra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Humankind Pharmaceutical And Lifesciences?
Humankind Pharmaceutical And Lifesciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Humankind Pharmaceutical And Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Humankind Pharmaceutical And Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.